Literature DB >> 1786519

Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open-chest dogs.

V Richard1, A Berdeaux, C D la Rochelle, J F Giudicelli.   

Abstract

1. The role of endothelial nitric oxide synthesis from L-arginine in the regulation of coronary vascular tone and myocardial tissue perfusion was evaluated in anaesthetized, open-chest dogs. Coronary blood flow was measured with an electromagnetic flow probe placed around the left circumflex coronary artery. Coronary vascular resistance was calculated from mean arterial blood pressure and mean coronary blood flow, whereas regional myocardial tissue flow was determined by use of the radioactive microspheres technique. 2. NG-monomethyl L-arginine (L-NMMA) and NG-nitro-L-arginine methyl ester (L-NAME), administered directly into the left circumflex artery, induced a small increase in arterial blood pressure and an increase in coronary vascular resistance. However, myocardial tissue perfusion, assessed by the microspheres technique (whether subendocardial, subepicardial, or transmural), was unaffected by L-NMMA or L-NAME. 3. Acetylcholine, administered intracoronarily, induced an increase in left circumflex coronary blood flow and a decrease in coronary vascular resistance, without affecting systemic haemodynamics. This coronary vasodilator effect of acetylcholine was markedly inhibited by L-NMMA and L-NAME, the latter being a more potent antagonist than the former. 4. These results indicate that the endothelial L-arginine pathway is largely responsible for the coronary vasodilator effect of acetylcholine. However, although basal release of nitric oxide from L-arginine apparently contributes to the regulation of resting coronary vascular tone, blockade of this pathway does not affect myocardial tissue perfusion, possibly because of compensatory mechanisms occurring at the level of small arterioles and/or capillaries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1786519      PMCID: PMC1908270          DOI: 10.1111/j.1476-5381.1991.tb12385.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Coronary vasoconstriction in the conscious rabbit following intravenous infusion of L-NG-nitro-arginine.

Authors:  R G Humphries; R D Carr; A K Nicol; W Tomlinson; S E O'Connor
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

2.  Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats.

Authors:  S M Gardiner; A M Compton; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

3.  Proximal and distal dog coronary arteries respond differently to basal EDRF but not to NO.

Authors:  U Hoeffner; C Boulanger; P M Vanhoutte
Journal:  Am J Physiol       Date:  1989-03

4.  Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester.

Authors:  S M Gardiner; A M Compton; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

5.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

7.  L-arginine evokes both endothelium-dependent and -independent relaxations in L-arginine-depleted aortas of the rat.

Authors:  V B Schini; P M Vanhoutte
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

8.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries.

Authors:  M Tschudi; V Richard; F R Bühler; T F Lüscher
Journal:  Am J Physiol       Date:  1991-01

10.  Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin.

Authors:  M A Kurz; K G Lamping; J N Bates; C L Eastham; M L Marcus; D G Harrison
Journal:  Circ Res       Date:  1991-03       Impact factor: 17.367

View more
  8 in total

Review 1.  Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide.

Authors:  D J Green; G O'Driscoll; B A Blanksby; R R Taylor
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

2.  The role of nitric oxide in the initiation and in the duration of some vasodilator responses in the coronary circulation.

Authors:  D Gattullo; P Pagliaro; R J Linden; A Merletti; G Losano
Journal:  Pflugers Arch       Date:  1995-05       Impact factor: 3.657

3.  Minimal role of nitric oxide in basal coronary flow regulation and cardiac energetics of blood-perfused isolated canine heart.

Authors:  A Saeki; F A Recchia; H Senzaki; D A Kass
Journal:  J Physiol       Date:  1996-03-01       Impact factor: 5.182

4.  Possible involvement of L-arginine-nitric oxide pathway in modulating regional blood flow to brown adipose tissue of rats.

Authors:  Y Uchida; F Tsukahara; K Irie; T Nomoto; T Muraki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

5.  NG-nitro L-arginine methyl ester: systemic and pulmonary haemodynamics, tissue blood flow and arteriovenous shunting in the pig.

Authors:  E M van Gelderen; M O Den Boer; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

6.  Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs.

Authors:  O L Woodman; P Pannangpetch
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

7.  Reduced nitric oxide formation causes coronary vasoconstriction and impaired dilator responses to endogenous agonists and hypoxia in dogs.

Authors:  C Huckstorf; J Zanzinger; B Fink; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

8.  Comparison of the ability of nicardipine, theophylline and zaprinast to restore cardiovascular haemodynamics following inhibition of nitric oxide synthesis.

Authors:  N A Herity; J D Allen; B Silke; A A Adgey
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.